Skip to content

Anti Beta 2 Glycoprotein I Antibody Positivity C5139305

Published: July 22, 2026Updated: August 20, 2026

Antibodies targeting beta-2 glycoprotein I, a protein involved in blood clotting regulation. Associated with antiphospholipid syndrome, increasing risk of clots and pregnancy complications. Treatment often includes blood thinners.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Lower extremity edema

!

Acute stroke symptoms

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Dyspnea

(respiratory)

Hemolytic anemia

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anticoagulation therapy

Direct oral anticoagulants or vitamin K antagonists with target INR of 2-3 for thrombotic prevention. Treatment intensity based on prior thrombotic history and antibody profile.

medication
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Hydroxychloroquine

Immunomodulatory agent with antithrombotic properties, often used as adjunctive therapy in antiphospholipid syndrome. May reduce antibody levels and thrombotic risk.

medication

Additional treatment options

Statin therapy

HMG-CoA reductase inhibitors with anti-inflammatory and antithrombotic properties. May provide additional vascular protection beyond lipid lowering in high-risk patients.

medication

Thrombosis surveillance

Regular clinical assessment for signs of venous or arterial thrombosis including D-dimer testing and vascular imaging when indicated. Early detection allows prompt treatment escalation.

monitoring

Thrombotic risk factor modification

Smoking cessation, maintaining adequate hydration, and avoiding prolonged immobility. Compression stockings may be recommended for venous insufficiency.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Beta 2 Glycoprotein I Antibody Positivity C5139305?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Ruiz-Irastorza G, Martinez-Berriotxoa A, Radic M. International consensus guidelines on antiphospholipid antibody detection and clinical management. Ann Rheum Dis. 2022.

guideline2022
2

Zhang L, Chouhan A, Brewer C. Beta-2 glycoprotein I antibodies and thrombosis risk: A systematic review and meta-analysis. J Thromb Haemost. 2021.

meta_analysis2021
3

Oku K, Amengual O, Hisada R. Hydroxychloroquine efficacy in antiphospholipid antibody carriers: A randomized controlled trial. Arthritis Rheumatol. 2020.

clinical_trial2020
4

Giannakopoulos B, Krilis SA, Willis R. pathogenesis and clinical manifestations of anti-beta-2 glycoprotein I antibodies. N Engl J Med. 2023.

review2023

Medication Comparisons

Compare medications used to treat Anti Beta 2 Glycoprotein I Antibody Positivity C5139305. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy